Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00115674
Other study ID # NIDA-15774-1
Secondary ID 5R01CA141663-03K
Status Completed
Phase
First received
Last updated
Start date September 2002
Est. completion date March 2008

Study information

Verified date September 2018
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to understand the smoking behavior of female incarcerated smokers and to determine how smokers differ from non-smokers on measures of substance abuse, personality, criminal history, and mental illness


Recruitment information / eligibility

Status Completed
Enrollment 360
Est. completion date March 2008
Est. primary completion date March 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria:

- all smokers, non-smokers, and ex-smokers

Exclusion Criteria:

- inability to understand English and inability to be able to provide informed consent due to mental impairment

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Virginia Commonwealth University Richmond Virginia

Sponsors (3)

Lead Sponsor Collaborator
University of Alabama at Birmingham National Cancer Institute (NCI), National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

References & Publications (4)

Cropsey K, Eldridge GD, Ladner T. Smoking among female prisoners: an ignored public health epidemic. Addict Behav. 2004 Feb;29(2):425-31. — View Citation

Cropsey KL, Kristeller JL. Motivational factors related to quitting smoking among prisoners during a smoking ban. Addict Behav. 2003 Aug;28(6):1081-93. — View Citation

Cropsey KL, Kristeller JL. The effects of a prison smoking ban on smoking behavior and withdrawal symptoms. Addict Behav. 2005 Mar;30(3):589-94. — View Citation

Haller DL, Miles DR, Cropsey KL. Smoking stage of change is associated with retention in a smoke-free residential drug treatment program for women. Addict Behav. 2004 Aug;29(6):1265-70. — View Citation

See also
  Status Clinical Trial Phase
Completed NCT00995033 - Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®) Phase 2
Completed NCT01635075 - Acute Effects of Exercise in Smokers With Schizophrenia Phase 2
Completed NCT03498053 - Smoking Topography Study 2018 N/A